Evaxion - EBITDA 2020-2025 | EVAX
Evaxion - ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Evaxion - Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-14 |
| 2023 | $-22 |
| 2022 | $-25 |
| 2021 | $-26 |
| 2020 | $-16 |
| 2019 | $-11 |
| Evaxion - Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-5 |
| 2023-06-30 | $-6 |
| 2022-06-30 | $-6 |
| 2022-03-31 | $-6 |
| 2021-12-31 | $-8 |
| 2021-09-30 | $-6 |
| 2021-06-30 | $-7 |
| 2021-03-31 | $-5 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-3 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.003B | $0.003B |
| Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.858B | 58.34 |
| Doximity (DOCS) | United States | $11.546B | 53.45 |
| Hims & Hers Health (HIMS) | United States | $10.959B | 113.86 |
| Tempus AI (TEM) | United States | $10.129B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.936B | 61.50 |
| Hinge Health (HNGE) | United States | $3.363B | 0.00 |
| Privia Health (PRVA) | United States | $2.624B | 179.33 |
| Enovis (ENOV) | United States | $1.984B | 11.06 |
| Phreesia (PHR) | United States | $1.691B | 0.00 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.552B | 0.00 |
| Azenta (AZTA) | United States | $1.534B | 71.30 |
| 10x Genomics (TXG) | United States | $1.508B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 24.51 |
| Evolent Health (EVH) | United States | $1.383B | 117.80 |
| Claritev (CTEV) | United States | $0.815B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.594B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.477B | 0.00 |
| Talkspace (TALK) | United States | $0.457B | 136.50 |
| Veradigm (MDRX) | United States | $0.456B | 0.00 |
| Outset Medical (OM) | United States | $0.370B | 0.00 |
| TruBridge (TBRG) | United States | $0.345B | 766.33 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.272B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| American Well (AMWL) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.110B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.90 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.081B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.074B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.045B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |